AMCURE
amcure is a privately held, clinical-stage company developing peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. Established in 2012, amcure GmbH is a spin-off from the Karlsruhe Institute of Technology (KIT) and is supported by a grant from the German Federal Ministry of Education and Research. amcure leverages its in-depth knowledge of CD44 target biology to develop a novel therapeutic approach to treat metastatic squamous tumors. In cancer, blocking the extracellular target CD44v6 has a beneficial effect on several relevant receptor tyrosine kinase pathways. Their first-in-class CD44v6-inhibitor AMC303 entered clinical development in solid tumors in Q4 2016.
AMCURE
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Leopoldshafen, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.amcure.com
Total Employee:
1+
Status:
Active
Contact:
49 7247 934249-0
Total Funding:
12.75 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Apache Wordpress Plugins Microsoft Exchange Online
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Current Employees Featured
Founder
Investors List
LBBW VC
LBBW VC investment in Series B - amcure
KfW
KfW investment in Series B - amcure
Karlsruhe Institute of Technology
Karlsruhe Institute of Technology investment in Series B - amcure
S-Kap Unternehmensbeteiligungs
S-Kap Unternehmensbeteiligungs investment in Series B - amcure
Mittelstaendische Beteiligungsgesellschaft Baden-Wuerttemberg
Mittelstaendische Beteiligungsgesellschaft Baden-Wuerttemberg investment in Series B - amcure
LBBW VC
LBBW VC investment in Series A - amcure
Official Site Inspections
http://www.amcure.com Semrush global rank: 8.68 M Semrush visits lastest month: 270
- Host name: alfa3064.alfahosting-server.de
- IP address: 109.237.132.6
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "amcure"
amcure - Crunchbase Company Profile & Funding
Amcure is a privately held, clinical-stage company developing peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. Established in 2012, amcure GmbH …See details»
Amcure GmbH - [LSG] Life-Sciences-Germany.com - The Life …
Feb 27, 2012 amcure GmbH is a spin-off from the Karlsruhe Institute of Technology established in 2012. The company develops peptide-based compounds for the treatment of highly …See details»
amcure GmbH - LinkedIn
Amcure GmbH | 487 followers on LinkedIn. Developing a First-in-Class Drug Candidate for the Treatment of Metastatic Squamous Cancer | amcure, a spin-off from the Karlsruhe Institute of Technology ...See details»
Amcure 2025 Company Profile: Valuation, Funding & Investors
Amcure General Information Description. Operator of a biopharmaceutical company intended to develop peptide-based compounds for the treatment of metastatic forms of squamous cancer. …See details»
amcure (amcure GmbH) - Startbase
Legal Entity: amcure GmbH Location: Baden-Württemberg Overview Company Funding Product Team News Is this your company? Profile is not claimed et. This profile is created by the Startbase Analyst Team. If you are a team member of …See details»
amcure - Funding, Financials, Valuation & Investors - Crunchbase
Amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. ... Experience the new Crunchbase, powered by …See details»
amcure GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Mar 6, 2025 Explore amcure GmbH with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 8 literature, Drug:AMC-303. ... The statistics for drugs in the Pipeline is the …See details»
amcure Company Profile - Office Locations, Competitors, Revenue …
Amcure is a biopharmaceutical company developing first-in-class cancer therapeutics. The company develops peptide-based compounds for the treatment of highly metastatic forms of …See details»
amcure - Transparentprofile
Amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. People. Mannheim, Germany; entrepreneur …See details»
amcure - Products, Competitors, Financials, Employees, …
About amcure. amcure is a biotechnology company focused on developing innovative treatments for metastatic cancers. The company specializes in creating allosteric inhibitors that target the …See details»
amcure - Contacts, Employees, Board Members, Advisors
Amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. ... Experience the new Crunchbase, powered by …See details»
amcure GmbH - VentureRadar
Amcure leverages its exceptional knowledge of CD44 target biology to develop a pipeline of innovative therapeutic programs. In cancer, blocking the extracellular target CD44v6 could …See details»
Amcure GmbH - BioCentury Company Profiles - BCIQ
Dec 16, 2016 Amcure GmbH - BioCentury Company Profiles for the biopharma industrySee details»
amcure - Overview, News & Similar companies | ZoomInfo.com
View amcure (www.amcure.com) location in Baden-Wuerttemberg, Germany , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
amcure GmbH Information - RocketReach
The NAICS codes for amcure GmbH are [54, 54171, 541713, 541, 5417]. What is the SIC code for amcure GmbH? The SIC codes for amcure GmbH are [873, 87]. Top amcure GmbH …See details»
amcure (amcure GmbH) - Startbase
Die neusten Erwähnungen von amcure in Podcasts & Videos: Offene Jobs bei amcure: Weitere Startups in der Nähe von amcure. enOware. Startup 2014 Karlsruhe. enOware. Entwicklung …See details»
KIT - KIT - Media - Press Releases - Archive Press Releases - kit.edu
Jul 15, 2014 About amcure amcure GmbH is a spinoff of Karlsruhe Institute of Technology. It was established in 2012. The company develops peptide agents for the treatment of highly metastatic carcinomas. First development candidates …See details»
amcure GmbH - Falling Walls
As one of the very few companies, amcure develops a novel approach with a proven effect on the primary tumor, the tumor spreading (metastasis), as well the remission of already established …See details»
amcure GmbH:Company Profile & Technical Research,Competitor …
Amcure GmbH is a company that provides Pharmacy and Therapeutics, Cancer, Receptor tyrosine kinase and more. amcure GmbH is headquartered in Germany Baden-Württemberg. amcure GmbH was founded in 2011. amcure GmbH has a total of 49 patentsSee details»
Amcure - 2025 Funding Rounds & List of Investors - Tracxn
Apr 8, 2025 Amcure has raised a total funding of $13.2M over 3 rounds from 10 investors. Investors include BMBF, KfW and 8 others. Their latest funding round was of $6.38M on Dec …See details»